Interpace Biosciences
IDXG
#11365
Rank
N/A
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Interpace Biosciences (IDXG)

Earnings in 2026 (TTM): C$5.59 Million

According to Interpace Biosciences's latest financial reports the company's current earnings are C$36.14 Million. In 2025 the company made an earning of C$5.52 Million a decrease over its 2024 earnings that were of C$12.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Interpace Biosciences from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$5.59 M1.28%
2025 C$5.52 M-54.26%
2024 C$12.08 M303.23%
2023 C$2.99 M-144.63%
2022 -C$6.72 Million-60.98%
2021 -C$17.21 Million-52.04%
2020 -C$35.88 Million-2.68%
2019 -C$36.87 Million121.84%
2018 -C$16.62 Million-6.07%
2017 -C$17.69 Million96.31%
2016 -C$9.02 Million-86.7%
2015 -C$67.78 Million382.48%
2014 -C$14.05 Million134.35%
2013 -C$6 Million323.89%
2012 -C$1.42 Million-79.01%
2011 -C$6.74 Million29.08%
2010 -C$5.22 Million-82.57%
2009 -C$29.95 Million-39.28%
2008 -C$49.32 Million146.45%
2007 -C$20.02 Million-269.18%
2006 C$11.82 M-131.08%
2005 -C$38.06 Million-177.16%
2004 C$49.31 M78.33%
2003 C$27.65 M-142.02%
2002 -C$65.82 Million-469.63%
2001 C$17.8 M-68.92%
2000 C$57.28 M140.45%
1999 C$23.82 M
1997 C$3.36 M